Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Honglin Situ"'
Autor:
Neng Wang, Bowen Yang, Gulizeba Muhetaer, Shengqi Wang, Yifeng Zheng, Jiahong Lu, Min Li, Fengxue Zhang, Honglin Situ, Yi Lin, Zhiyu Wang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 149, Iss , Pp 112867- (2022)
Externí odkaz:
https://doaj.org/article/350eb2a310ad4295a361982a603c33e1
Autor:
Yifeng Zheng, Neng Wang, Shengqi Wang, Bowen Yang, Honglin Situ, Lidan Zhong, Yi Lin, Zhiyu Wang
Publikováno v:
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-17 (2020)
Abstract Background Recent findings suggested that premetastatic niche (PMN) is a prerequisite in mediating cancer metastasis. Previously we demonstrated that XIAOPI formula could inhibit breast cancer lung metastasis via inhibiting tumor associated
Externí odkaz:
https://doaj.org/article/fd5ce6ec68da4059bd7aebe0074ef2a7
Autor:
Yifeng Zheng, Juping Zhang, Wanqing Huang, Linda L. D. Zhong, Neng Wang, Shengqi Wang, Bowen Yang, Xuan Wang, Bo Pan, Honglin Situ, Yi Lin, Xiaoyan Liu, Yafei Shi, Zhiyu Wang
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Chronic psychological stress is closely correlated with breast cancer growth and metastasis. Sini San (SNS) formula is a classical prescription for relieving depression-related symptoms in traditional Chinese medicine (TCM). Current researches have s
Externí odkaz:
https://doaj.org/article/5ef94a3f0dfc4389b747891bfd972332
Autor:
Neng Wang, Bowen Yang, Juping Zhang, Yifeng Zheng, Shengqi Wang, Xiaotong Zhang, Honglin Situ, Yi Lin, Zhiyu Wang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 121, Iss , Pp 109569- (2020)
XIAOPI formula has been approved for mammary hyperplasia treatment by National Medical Products Administration in China. However, the absorbed substances of XIAOPI formula and their influences on metabolic pathways are largely remained unknown. Liqui
Externí odkaz:
https://doaj.org/article/b868be487a6d4eb4b21ae5c2afe5043e
XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy
Autor:
Neng Wang, Bowen Yang, Gulizeba Muhetaer, Shengqi Wang, Yifeng Zheng, Jiahong Lu, Min Li, Fengxue Zhang, Honglin Situ, Yi Lin, Zhiyu Wang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 120, Iss , Pp - (2019)
XIAOPI formula is a national approved drug prescribed to patients with high breast cancer risk. Previously we demonstrated that XIAOPI formula could inhibit breast cancer metastasis via suppressing CXCL1 expression, and postulated that “autophagy i
Externí odkaz:
https://doaj.org/article/3bba73feba5d472581f34bcbbce3629a
Autor:
Shengqi Wang, Xiaoyan Liu, Renlun Huang, Yifeng Zheng, Neng Wang, Bowen Yang, Honglin Situ, Yi Lin, Zhiyu Wang
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Macrophages are the most abundant stromal cells associated with the host immune system in multiple malignancies including breast cancer. With proven clinical efficacy and no noticeable adverse effects, XIAOPI formula (XPS) has been approved for breas
Externí odkaz:
https://doaj.org/article/78075ee34c48406dab24dc2b5c77bd45
Autor:
Honglin Situ, Yi Lin, Bowen Yang, Neng Wang, Yifeng Zheng, Lidan Zhong, Zhiyu Wang, Shengqi Wang
Publikováno v:
Cell Communication and Signaling : CCS
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-17 (2020)
Cell Communication and Signaling, Vol 18, Iss 1, Pp 1-17 (2020)
Background Recent findings suggested that premetastatic niche (PMN) is a prerequisite in mediating cancer metastasis. Previously we demonstrated that XIAOPI formula could inhibit breast cancer lung metastasis via inhibiting tumor associated macrophag
Autor:
Zhiyu Wang, Bowen Yang, Yi Lin, Shengqi Wang, Yifeng Zheng, Honglin Situ, Neng Wang, Juping Zhang, Xiaotong Zhang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 121, Iss, Pp 109569-(2020)
XIAOPI formula has been approved for mammary hyperplasia treatment by National Medical Products Administration in China. However, the absorbed substances of XIAOPI formula and their influences on metabolic pathways are largely remained unknown. Liqui
Autor:
Yifeng Zheng, Zhiyu Wang, Shengqi Wang, Min Li, Bowen Yang, Honglin Situ, Jianping Chen, Yi Lin, Meiqi Xie, Neng Wang, Pengxi Liu
Publikováno v:
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Oxidative Medicine and Cellular Longevity, Vol 2019 (2019)
Targeting aberrant metabolism is a promising strategy for inhibiting cancer growth and metastasis. Research is now geared towards investigating the inhibition of glycolysis for anticancer drug development. Betulinic acid (BA) has demonstrated potent
Autor:
Li ping Dian, Liping Ren, Qianjun Chen, Rui Xu, Honglin Situ, Fan Tang, Xiaoqing Wei, Huijun Zhao, Yuzhu Zhang
Publikováno v:
Journal of Clinical Oncology. 38:e12519-e12519
e12519 Background: The aim of this analysis is to study the prognostic impacts of adjuvant radiotherapy on pure mucinous breast carcinoma patients in different age stages. Methods: Patients diagnosed pure mucinous breast carcinoma between 1998 and 20